Chemotherapy for advanced bladder cancer: 'Midsummer Night's Dream' or 'Much Ado About Nothing'?
作者信息
Raghavan D
机构信息
Urological Cancer Research Unit, Royal Prince Alfred Hospital, Sydney, Australia.
出版信息
Br J Cancer. 1990 Sep;62(3):337-40. doi: 10.1038/bjc.1990.293.
Abstract
摘要
相似文献
1
Chemotherapy for advanced bladder cancer: 'Midsummer Night's Dream' or 'Much Ado About Nothing'?
Br J Cancer. 1990 Sep;62(3):337-40. doi: 10.1038/bjc.1990.293.
2
Neoadjuvant androgen deprivation therapy through intense inhibition of the androgen target: "" or ""?
Ann Transl Med. 2019 Sep;7(Suppl 6):S230. doi: 10.21037/atm.2019.07.84.
3
Endpoints of clinical trials in invasive bladder cancer.
Semin Oncol. 1990 Oct;17(5):619-27.
4
Progress and controversies in chemotherapy of advanced unresectable and/or metastatic carcinoma of the bladder.
Prog Clin Biol Res. 1988;269:539-49.
5
Chemotherapy for bladder cancer.
N Engl J Med. 2003 Dec 4;349(23):2272-3; author reply 2272-3.
6
Adjuvant chemotherapy of bladder cancer.
Prog Clin Biol Res. 1988;260:545-9.
7
Neoadjuvant (induction) chemotherapy in advanced bladder carcinoma.
Int Urol Nephrol. 1993;25(3):259-63.
8
Neoadjuvant chemotherapy in bladder cancer.
Urology. 1988 Feb;31(2 Suppl):9-12.
9
Is neoadjuvant chemotherapy the answer for bladder cancer?
Lancet. 1999 Aug 14;354(9178):526-7. doi: 10.1016/S0140-6736(99)00210-X.
10
Chemotherapy for bladder cancer.
N Engl J Med. 2003 Dec 4;349(23):2272-3; author reply 2272-3. doi: 10.1056/NEJM200312043492323.
引用本文的文献
1
Evaluating prognostic factors: implications for measurement of health care outcome.
J Epidemiol Community Health. 1992 Aug;46(4):323-6. doi: 10.1136/jech.46.4.323.
本文引用的文献
1
Chemotherapy of human solid tumors with 5-fluorouracil.
Cancer. 1960 Nov-Dec;13:1230-9. doi: 10.1002/1097-0142(196011/12)13:6<1230::aid-cncr2820130612>3.0.co;2-d.
2
Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer.
J Urol. 1984 Jun;131(6):1069-72. doi: 10.1016/s0022-5347(17)50809-5.
3
Cis-diamminedichloroplatinum (DDP) as initial treatment of invasive bladder cancer.
Br J Urol. 1984 Jun;56(3):296-300. doi: 10.1111/j.1464-410x.1984.tb05390.x.
4
Cisplatin and full dose irradiation for patients with invasive bladder carcinoma: a preliminary report of tolerance and local response.
J Urol. 1984 Nov;132(5):899-903. doi: 10.1016/s0022-5347(17)49938-1.
5
A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A National Bladder Cancer Collaborative Group A Study.
Cancer. 1983 Sep 1;52(5):767-72. doi: 10.1002/1097-0142(19830901)52:5<767::aid-cncr2820520502>3.0.co;2-p.
6
Intra-arterial chemotherapy of infiltrative bladder carcinoma.
Eur Urol. 1985;11(4):220-3. doi: 10.1159/000472502.
7
Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium.
J Urol. 1985 Mar;133(3):403-7. doi: 10.1016/s0022-5347(17)48996-8.
8
Initial intravenous cis-platinum therapy: improved management for invasive high risk bladder cancer?
J Urol. 1985 Mar;133(3):399-402. doi: 10.1016/s0022-5347(17)48995-6.
9
Chemotherapy before radiotherapy for T3 bladder cancer. A pilot study.
Br J Urol. 1985 Aug;57(4):434-7. doi: 10.1111/j.1464-410x.1985.tb06304.x.
10
The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: a Northern California Oncology Group study.
J Urol. 1985 Dec;134(6):1118-21. doi: 10.1016/s0022-5347(17)47651-8.
Zotero 插件